Michael Martin Breen - Net Worth and Insider Trading
Michael Martin Breen Net Worth
The estimated net worth of Michael Martin Breen is at least $354,120 dollars as of 2024-12-29. Michael Martin Breen is the Director of Prairie Operating Co and owns about 40,064 shares of Prairie Operating Co (PROP) stock worth over $288,060. Michael Martin Breen is also the Executive Chairman/Interim CEO of GT Biopharma Inc and owns about 21,874 shares of GT Biopharma Inc (GTBP) stock worth over $66,059. Details can be seen in Michael Martin Breen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Martin Breen has not made any transactions after 2023-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Martin Breen
Michael Martin Breen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Martin Breen owns 2 companies in total, including GT Biopharma Inc (GTBP) , and Prairie Operating Co (PROP) .
Click here to see the complete history of Michael Martin Breen’s form 4 insider trades.
Insider Ownership Summary of Michael Martin Breen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTBP | GT Biopharma Inc | 2023-04-11 | director & Exec. Chair. and Interim CEO |
| PROP | Prairie Operating Co | 2023-05-03 | director |
Michael Martin Breen Latest Holdings Summary
Michael Martin Breen currently owns a total of 2 stocks. Among these stocks, Michael Martin Breen owns 40,064 shares of Prairie Operating Co (PROP) as of May 3, 2023, with a value of $288,060 and a weighting of 81.35%. Michael Martin Breen also owns 21,874 shares of GT Biopharma Inc (GTBP) as of April 11, 2023, with a value of $66,059 and a weighting of 18.65%.
Latest Holdings of Michael Martin Breen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PROP | Prairie Operating Co | 2023-05-03 | 40,064 | 7.19 | 288,060 |
| GTBP | GT Biopharma Inc | 2023-04-11 | 21,874 | 3.02 | 66,059 |
Holding Weightings of Michael Martin Breen
Michael Martin Breen Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Martin Breen has made a total of 1 transactions in Prairie Operating Co (PROP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prairie Operating Co is the acquisition of 32,064 shares on May 3, 2023, which cost Michael Martin Breen around $100,772.
According to the SEC Form 4 filings, Michael Martin Breen has made a total of 1 transactions in GT Biopharma Inc (GTBP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GT Biopharma Inc is the acquisition of 1,667 shares on April 11, 2023, which cost Michael Martin Breen around $25,000.
Insider Trading History of Michael Martin Breen
- 1
Michael Martin Breen Trading Performance
GuruFocus tracks the stock performance after each of Michael Martin Breen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Martin Breen is 31.82%. GuruFocus also compares Michael Martin Breen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Martin Breen within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Martin Breen's insider trading performs compared to the benchmark.
Performance of Michael Martin Breen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.08 | | | | | |
| Relative Return to S&P 500(%) | -26.69 | | | | | |
Michael Martin Breen Ownership Network
Michael Martin Breen Owned Company Details
What does GT Biopharma Inc do?
Who are the key executives at GT Biopharma Inc?
Michael Martin Breen is the director & Exec. Chair. and Interim CEO of GT Biopharma Inc. Other key executives at GT Biopharma Inc include CFO & Secretary Manu Ohri , Pres. of R&D & CMO Gregory Berk , and Acting Chief Financial Officer Gavin Choy .
GT Biopharma Inc (GTBP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of GT Biopharma Inc (GTBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GT Biopharma Inc (GTBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
GT Biopharma Inc (GTBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
GT Biopharma Inc Insider Transactions
Michael Martin Breen Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Martin Breen. You might contact Michael Martin Breen via mailing address: Lowsley House 133 Headley Road, Liphook X0 Gu30 7pu.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
